Saturday, March 17, 2018
Company News: Page (1) of 1 - 01/12/18 Email this story to a friend. email article Print this page (Article printing at page facebook
GSK receives FDA approval for expanded indication for FLUARIX® QUADRIVALENT (Influenza Vaccine) for persons 6 months and older
(January 12, 2018)
This article is no longer available,but here are some related topics.

Page: 1

Related Keywords:Medicine,Disease,healthcare,Surgery,Children,Science,Medical,Adults,Children,Other,Women,
Related Sites: DMN Newswire ,   HTN - Health Technology Net
Related Newsletter: Tutorial Finder ,   Review Seeker ,   DMN Newswire Newsletter

Our Privacy Policy --- About The Health Technology - Contact Us - Advertise With Us - Privacy Guidelines